A Study of Endometriosis Biomarkers

Overview

Información sobre este estudio

The purpose of this study is to analytically validate a cluster of specific biomarkers for endometriosis diagnosis and disease recurrence. This signature will be tested on endometrium and blood from 975 patients, divided in two groups : 550 patients affected by endometriosis and 225 patients unaffected (controls). EndoSearch is not about drug or medical device assessment but a research study for biomarker analytical validation purpose.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

Endometriosis Patients 

  • Woman, 18 to 45 years old.
  • Patients with endometriosis suspicion, associated adenomyosis is accepted.
  • Freely signature of the consent form.
  • Patient needs laparoscopy for endometriosis purpose (first intervention or recurrence) regardless of the endometriosis type (superficial, ovarian or deep).
  • Possibility of follow up during 2 years.

 Healthy Voluntary Patients

  •  Woman, 18 to 45 years old.
  • Freely signature of the consent form.
  • Patient needs laparoscopy for another indication than endometriosis, adenomyosis, uterine fibroma & other fibroid pathologies (ex of surgeries: tubular sterilization, ovarian non-fibroid cyst, urinary incontinence requiring ureteral intervention).

Exclusion Criteria:

Endometriosis Patients

  • Refusal or linguistic or psychic incapacity to sign informed consent.
  • No internet access or refusal to use new technologies.
  • Minor woman (under 18 years old).
  • Pregnancy or breastfeeding.
  • Menopause.
  • Evidence of adenomyosis without endometriosis.
  • All metabolic pathology, endocrine, chronical infectious or malignant.
  • Endometriosis negative result at visual and histological examination by anatomopathologist of the clinical centre.

 Healthy Voluntary Patients

  • Refusal or linguistic or psychic incapacity to sign informed consent.
  • No internet access or refusal to use new technologies.
  • Minor woman (under 18 years old).
  • Pregnancy or breastfeeding.
  • Menopause.
  • Adenomyosis.
  • All metabolic pathology, endocrine, chronical infectious or malignant.
  • Endometriosis positive result at visual and histological examination by anatomopathologist of the clinical centre.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Scottsdale/Phoenix, Ariz.

Investigador principal de Mayo Clinic

Paul Magtibay, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20492221

Mayo Clinic Footer